文献速递免疫规划传染病防控与疫情报告卫生政策与健康促进

东南亚区域乙肝控制进展(2016—2019年)

Progress Toward Hepatitis B Control - South-East Asia Region, 2016-2019.
PubMed 文献 · MMWR Morb Mortal Wkly Rep · 2020-07-31

本报告描述2016—2019年WHO东南亚区域乙肝控制进展。区域乙肝疫苗三剂覆盖率由89%升至91%,首剂及时接种率由34%升至54%;至2019年四国经验证达成控制目标。

要点

  • 区域乙肝疫苗三剂覆盖率2016—2019年由89%升至91%。
  • 乙肝疫苗首剂及时接种率由34%升至54%,仍为薄弱环节。
  • 2019年九国三剂覆盖率达≥90%,仅三国首剂及时接种达≥90%。

核心结论

  • 东南亚区域乙肝控制取得进展,但首剂及时接种率仍偏低,需用已验证策略提升覆盖率。

主要发现

  • 2016年区域11国均将乙肝疫苗纳入国家免疫规划,8国提供首剂及时接种。
  • 2016—2019年区域三剂覆盖率由89%升至91%,首剂及时接种率由34%升至54%。
  • 2019年九国三剂覆盖率达≥90%,8个提供首剂的国家中仅3国首剂及时接种达≥90%。

关键数值与推荐

  • 区域控制目标为2020年≥5岁儿童HBsAg血清流行率≤1%。
  • 策略包括三剂覆盖率≥90%、提供首剂及时接种、较大儿童补种及高危成人接种。

临床怎么用

  • 优先提升乙肝疫苗首剂及时接种率与三剂覆盖率,并开展儿童代表性血清学调查以验证目标。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

In 2015, the World Health Organization (WHO) South-East Asia Region (SEAR)* reported an estimated 40 million persons living with chronic hepatitis B virus (HBV) infection and 285,000 deaths from complications of chronic infection, cirrhosis, and hepatocellular carcinoma (1). Most chronic HBV infections, indicated by the presence of hepatitis B surface antigen (HBsAg) on serologic testing, are acquired in infancy through perinatal or early childhood transmission (2). To prevent perinatal and childhood infections, WHO recommends that all infants receive at least 3 doses of hepatitis B vaccine (HepB), including a timely birth dose (HepB-BD)† (1). In 2016, the SEAR Immunization Technical Advisory Group endorsed a regional hepatitis B control goal with a target of achieving hepatitis B surface antigen (HBsAg) seroprevalence of ≤1% among children aged ≥5 years by 2020, which is in line with the WHO Global Health Sector Strategy on Viral Hepatitis 2016-2021 (2,3). The South-East Asia Regional Vaccine Action Plan 2016-2020 (SEARVAP) (4) identified the acceleration of hepatitis B control as one of the eight regional goals for immunization. The plan outlined four main strategies for achieving hepatitis B control: 1) achieving ≥90% coverage with 3 doses of HepB (HepB3), 2) providing timely vaccination with a HepB birth dose (HepB-BD), 3) providing catch-up vaccination of older children, and 4) vaccinating adult populations at high risk and health care workers (1,4). In 2019, SEAR established a regional expert panel on hepatitis B to assess countries' HBV control status. This report describes the progress made toward hepatitis B control in SEAR during 2016-2019. By 2016, all 11 countries in the region had introduced HepB in their national immunization programs, and eight countries had introduced HepB-BD. During 2016-2019, regional HepB3 coverage increased from 89% to 91%, and HepB-BD coverage increased from 34% to 54%. In 2019, nine countries in the region achieved ≥90% HepB3 coverage, and three of the eight countries that provide HepB-BD achieved ≥90% HepB-BD coverage. By December 2019, four countries had been verified to have achieved the hepatitis B control goal. Countries in the region can make further progress toward hepatitis B control by using proven strategies to improve HepB-BD and HepB3 coverage rates. Conducting nationally representative hepatitis B serosurveys among children will be key to tracking and verifying the regional control targets.

来源:MMWR Morb Mortal Wkly Rep,查看原文。版权归原作者所有。

引用

  1. Sandhu HS, Roesel S, Sharifuzzaman M, et al. Progress Toward Hepatitis B Control - South-East Asia Region, 2016-2019. MMWR Morb Mortal Wkly Rep. 2020. PMID: 32730237. doi:10.15585/mmwr.mm6930a2

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。